104 Chapter 4 116. Kruk D, Wisman M, Noordhoek JA, Nizamoglu M, Jonker MR, de Bruin HG, Arevalo Gomez K, Ten Hacken NHT, Pouwels SD, Heijink IH. Paracrine Regulation of Alveolar Epithelial Damage and Repair Responses by Human Lung-Resident Mesenchymal Stromal Cells. Cells 2021: 10(11): 2860. 117. Benam KH, Novak R, Ferrante TC, Choe Y, Ingber DE. Biomimetic smoking robot for in vitro inhalation exposure compatible with microfluidic organ chips. Nat Protoc 2020: 15(2): 183-206. 118. Hirai H, Liang X, Sun Y, Zhang Y, Zhang J, Chen YE, Mou H, Zhao Y, Xu J. The sodium/glucose cotransporters as potential therapeutic targets for CF lung diseases revealed by human lung organoid swelling assay. Mol Ther Methods Clin Dev 2022: 24: 11-19. 119. Hannan NR, Sampaziotis F, Segeritz CP, Hanley NA, Vallier L. Generation of Distal Airway Epithelium from Multipotent Human Foregut Stem Cells. Stem Cells Dev 2015: 24(14): 1680-1690. 120. Calucho M, Gartner S, Barranco P, FernandezAlvarez P, Perez RG, Tizzano EF. Validation of nasospheroids to assay CFTR functionality and modulator responses in cystic fibrosis. Sci Rep 2021: 11(1): 15511. 121. Sette G, Lo Cicero S, Blacona G, Pierandrei S, Bruno SM, Salvati V, Castelli G, Falchi M, Fabrizzi B, Cimino G, De Maria R, Biffoni M, Eramo A, Lucarelli M. Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells. Eur Respir J 2021: 58(6): 2100908. 122. Strikoudis A, Cieślak A, Loffredo L, Chen Y-W, Patel N, Saqi A, Lederer DJ, Snoeck H-W. Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells. Cell Rep 2019: 27(12): 3709-3723.e3705. 123. Felder M, Trueeb B, Stucki AO, Borcard S, Stucki JD, Schnyder B, Geiser T, Guenat OT. Impaired Wound Healing of Alveolar Lung Epithelial Cells in a Breathing Lung-On-AChip. Front Bioeng Biotechnol 2019: 7: 3. 124. van Rijt SH, Bolukbas DA, Argyo C, Datz S, Lindner M, Eickelberg O, Konigshoff M, Bein T, Meiners S. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors. ACS Nano 2015: 9(3): 2377-2389. 125. Dong M, Philippi C, Loretz B, Nafee N, Schaefer UF, Friedel G, Ammon-Treiber S, Griese EU, Lehr CM, Klotz U, Murdter TE. Tissue slice model of human lung cancer to investigate telomerase inhibition by nanoparticle delivery of antisense 2’-O-methyl-RNA. Int J Pharm 2011: 419(1-2): 33-42. 126. Salmon H, Franciszkiewicz K, Damotte D, Dieu-Nosjean MC, Validire P, Trautmann A, Mami-Chouaib F, Donnadieu E. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. J Clin Invest 2012: 122(3): 899-910. 127. Shi R, Radulovich N, Ng C, Liu N, Notsuda H, Cabanero M, Martins-Filho SN, Raghavan V, Li Q, Mer AS, Rosen JC, Li M, Wang YH, Tamblyn L, Pham NA, Haibe-Kains B, Liu G, Moghal N, Tsao MS. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer. Clin Cancer Res 2020: 26(5): 1162-1174. 128. Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W. Human Lung AdenocarcinomaDerived Organoid Models for Drug Screening. iScience 2020: 23(8): 101411.
RkJQdWJsaXNoZXIy MTk4NDMw